about
Decreased circulating visfatin is associated with improved disease activity in early rheumatoid arthritis: data from the PERAC cohortHigh levels of metastasis-inducing S100A4 protein and treatment outcome in early rheumatoid arthritis: data from the PERAC cohort.PPARA intron polymorphism associated with power performance in 30-s anaerobic Wingate Test.The metastasis promoting protein S100A4 levels associate with disease activity rather than cancer development in patients with idiopathic inflammatory myopathies.Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis.MicroRNA-125b: association with disease activity and the treatment response of patients with early rheumatoid arthritisCorrection: PPARA Intron Polymorphism Associated with Power Performance in 30-s Anaerobic Wingate TestThe level of fatty acid-binding protein 4, a novel adipokine, is increased in rheumatoid arthritis and correlates with serum cholesterol levels.A randomised controlled trial of roller versus centrifugal cardiopulmonary bypass pumps in patients undergoing pulmonary endarterectomy.FRI0520 Association Study of the BAFF Genetic Variations in Two Independent Cohorts with Idiopathic Inflammatory MyopathiesTHU0528 Decrease in Circulating Visfatin Levels is Associated with Disease Activity Improvement in Early Rheumatoid ArthritisMetastasis-inducing S100A4 protein is associated with treatment response in patients with recent-onset rheumatoid arthritisAdipokine profile is modulated in subcutaneous adipose tissue by TNF inhibitors in patients with rheumatoid arthritisPrediction of compartment syndrome based on analysis of biochemical parametersPhosphorus Removal in Low-Flux Hemodialysis, High-Flux Hemodialysis, and HemodiafiltrationDifferential impact on acute kidney injury incidence between on- and off pump coronary artery bypass grafting in octogenarians
P50
Q30839061-4F7B231C-2CC4-4FC4-8BA8-7470022C3715Q30876263-8F4174FE-7999-4FF6-8548-ED009DE5ED2EQ34149893-1125D89D-6F21-46E6-888A-4C25E7AC61CDQ34560305-AD6C2C65-3564-41DC-8756-B2D4CD57F928Q35617658-2275EED1-249A-4FF8-B66D-08C65F4D689AQ36960767-1ABF0F67-F147-46B8-B6E2-A930C4841ECBQ42400375-C9B9AB49-E181-44FC-8AD3-56C1A7A487DFQ44832774-46B708A1-C955-4FD5-A1EF-08EFC796AF94Q47808332-339E3144-E2AB-42B8-ABAB-26E0D94F9944Q57752335-8C00A07F-8DB3-4037-A938-3F2FF24E0C07Q57752350-E589292C-DC85-45F3-8273-6C8D6AAAF8BDQ57752504-7F8A7555-AA99-49D8-A7F3-9C05E02B55DEQ57752526-2E3DD778-3DE6-4450-8146-DCF79307324EQ85646066-6B5FEACF-7545-4B34-9C9B-C7839D5E8536Q86720827-F934EB0F-36E1-45E9-82F7-3A24CB818280Q87992954-1200AA94-5FD9-4ABD-B59E-639C16173E6D
P50
description
researcher, ORCID id # 0000-0002-9096-1432
@en
wetenschapper
@nl
name
Ondrej Pecha
@ast
Ondrej Pecha
@en
Ondrej Pecha
@es
Ondrej Pecha
@nl
type
label
Ondrej Pecha
@ast
Ondrej Pecha
@en
Ondrej Pecha
@es
Ondrej Pecha
@nl
prefLabel
Ondrej Pecha
@ast
Ondrej Pecha
@en
Ondrej Pecha
@es
Ondrej Pecha
@nl
P106
P31
P496
0000-0002-9096-1432